| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.04 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.095 | 0.04 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.094 | 0.04 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.062 | 0.05 |